3D Printing in Healthcare Market Forecasts 2023: Market Share, Size, Trend and more
IMARC Group has recently released a new research study “3D Printing in Healthcare Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”, offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends, and competitive landscape to understand the current and future market scenarios.
What are the growth prospects of 3D Printing in Healthcare Market?
The global 3D Printing in healthcare market size reached US$ 2.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach a value of US$ 6.5 Billion by 2028, exhibiting a growth rate (CAGR) of 15.1% during 2023-2028.
Covid-19 Impact:
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
What is the 3D printing in healthcare?
Three-dimensional (3D) printing in healthcare is used to make 3D objects employed in the healthcare sector. It utilizes a layer-by-layer addition technique to create physical objects from 3D digital data from a computer-aided design (CAD) or a magnetic resonance image (MRI). It assists in developing customized medical products and equipment, such as drill guides and prosthetics, and generates patient-specific replicas of blood vessels, bones, and organs. It also saves time, minimizes cost, ensures faster and more effective delivery of medical services, reduces operative risk and susceptibility to infections, provides quick recovery, and minimizes hospital stays. As a result, 3D printing is gaining traction in the healthcare sector across the globe.
Request For Sample Report: https://www.imarcgroup.com/3d-printing-in-healthcare-market/requestsample
What are the key factors driving the global 3D printing in healthcare market?
The market is primarily driven by the increasing demand for 3D printing in the healthcare sector. This can be attributed to the growing prevalence of chronic illnesses such as cancer and respiratory and cardiovascular disorders (CVDs) across the globe.
In addition, the widespread adoption of 3D printing in liver modeling and developing bone, medical implants, tissue, and the surging need for stem cell solutions, regenerative medicines, and cancer therapeutics are contributing to the market growth. Moreover, emerging technological advancements in 3D printing to enable customization and personalization of medical products, drugs, and equipment such as orthopedic implants, external prosthetics, and dental restorations represent another major growth-inducing factor. Besides this, the escalating demand for 3D printing medical devices, as it minimizes the duration of anesthesia exposure and surgeries, is providing a positive thrust to the market growth. Furthermore, the extensive investments by key players in research and development (R&D) activities to develop advanced 3D printers are creating a favorable market outlook.
Who are the key players/companies in the Global 3D Printing in Healthcare Market?
3D Systems Inc., Desktop Metal Inc., EOS GmbH, Formlabs, Materialise NV, Organovo Holding Inc., Oxford Performance Materials Inc., Prodways Tech, Proto Labs Inc., Renishaw plc, SLM Solutions Group AG and Stratasys Ltd.
Report Segmentation:
The report has been segmented the market into following categories:
Breakup by Material:
- Polymer
- Metals
- Ceramic
- Organic
Breakup by Technology:
- Droplet Deposition
- Fused Filament Fabrication (FFF) Technology
- Low-temperature Deposition Manufacturing (LDM)
- Multiphase Jet Solidification (MJS)
- Photopolymerization
- Stereolithography (SLA)
- Continuous Liquid Interface Production (CLIP)
- Two-photon Polymerization (2PP)
- Laser Beam Melting
- Selective Laser Sintering (SLS)
- Selective Laser Melting (SLM)
- Direct Metal Laser Sintering (DMLS)
- Electronic Beam Melting (EBM)
- Laminated Object Manufacturing
- Others
Breakup by Application:
- External Wearable Devices
- Hearing Aids
- Prosthesis and Orthotics
- Dental Products
- Clinical Study Devices
- Drug Testing
- Anatomical Models
- Implants
- Surgical Guides
- Cranio-maxillofacial Implants
- Orthopedic Implants
- Tissue Engineering
Breakup by End User:
- Medical and Surgical Centers
- Pharmaceutical and Biotechnology Companies
- Academic Institutions
By Geography:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=6116&flag=C
Key highlights of the report:
- Market Performance (2017-2022)
- Market Outlook (2023- 2028)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 |
Africa and Europe :- +44-702-409-7331 |
Asia: +91-120-433-0800, +91-120-433-0800
0